Literature DB >> 385188

Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.

S P Ballou, I Kushner.   

Abstract

To investigate the suggestion that qualitative immunochemical characteristics of antibodies to DNA (anti-DNA) may be of importance in the pathogenesis of nephritis in systemic lupus erythematosus (SLE), we used the Crithidia luciliae (CL) immunofluorescence test to determine the titre, immunoglobulin (Ig) class and complement-fixing activity of anti-DNA in thirty-five patients with active SLE. Eighteen of these patients had active lupus nephritis (Group I) and the remaining seventeen had no clinical evidence of renal involvement (Group II). Anti-DNA was detected in twenty-eight patients, and was present more frequently and in higher titre (P less than 0.01) in Group I than in Group II. Anti-DNA of all three Ig classes studied (IgG, IgM and IgA) was present in twenty-three out of twenty-eight cases. The ratio of IgG to IgM anti-DNA did not differ in the two groups of patients. Complement-fixing antibodies were detected in thirteen patients in Group I and five patients in Group II. The titre of complement-fixing activity was strongly correlated with titre of anti-DNA. DNA-binding capacity was also determined in these by a millipore filter (MF) assay. A highly significant correlation between DNA binding by MF and CL was found in Group I patients, while no correlation was found in Group II patients. These findings suggest that (1) anti-DNA with specificity for determinants found in CL, presumably native DNA, are more highly correlated with the presence of active renal lupus than are antibodies directed toward other DNA determinants, and (2) the major characteristic of anti-DNA found to be associated with nephritis was quantity of antibody. Most patients had anti-DNA of all Ig classes regardless of the presence of renal disease. Complement-fixing activity of anti-DNA could not be related to the occurrence of renal disease independently of anti-DNA titre.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385188      PMCID: PMC1537673     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  S P CASALS; G J FRIOU; L L MYERS
Journal:  Arthritis Rheum       Date:  1964-08

2.  Analysis of DNA structure by hydroxyapatite columns and ethidium bromide fluorescence techniques. A comparative study and effect on DNA binding.

Authors:  P Davis; M Burrington; A S Russell; A R Morgan
Journal:  Arthritis Rheum       Date:  1978-05

3.  DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis.

Authors:  R D Sontheimer; J N Gilliam
Journal:  Clin Immunol Immunopathol       Date:  1978-08

4.  Antibodies to double-stranded DNA. A comparison of the indirect immunofluorescent test using crithidia luciliae and the DNA-binding assay.

Authors:  M J Deegan; S E Walker; S E Lovell
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

5.  Lupus nephropathy without clinical renal involvement.

Authors:  S K Mahajan; N G Ordóñez; P J Feitelson; V S Lim; B H Spargo; A I Katz
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

6.  An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA.

Authors:  W Crowe; I Kushner
Journal:  Arthritis Rheum       Date:  1977-04

Review 7.  Synergy, additivism and antagonism in immunosuppression. A critical review.

Authors:  M C Berenbaum
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

8.  Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus.

Authors:  S P Ballou; I Kushner
Journal:  Arthritis Rheum       Date:  1979-04

9.  An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay.

Authors:  A Chubick; R D Sontheimer; J N Gilliam; M Ziff
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

10.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more
  16 in total

1.  Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics.

Authors:  A Ruffatti; A Calligaro; T Del Ross; M T Bertoli; A Doria; L Rossi; S Todesco
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

2.  Classifying lupus.

Authors:  M L Snaith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

3.  DNA antibodies with and without complement-binding ability.

Authors:  A M Teppo; P Kurki; T Helve; O Wegelius
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 4.  A comparison of assays used for the detection of antibodies to DNA.

Authors:  R Smeenk; K Brinkman; H van den Brink; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; M Leirisalo; E Johansson; G Gripenberg
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

6.  Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; T Helve
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 7.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

8.  Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.

Authors:  R P Taylor; B S Andrews; K W Morley; T Conlon
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

9.  Detection of antibodies to DNA: a technical assessment.

Authors:  R Smeenk; M Hylkema
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

10.  Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.

Authors:  K Sekita; T Doi; E Muso; H Yoshida; K Kanatsu; Y Hamashima
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.